Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,264 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes.
Sharif NA, Xu SX, Crider JY, McLaughlin M, Davis TL. Sharif NA, et al. Among authors: mclaughlin m. J Ocul Pharmacol Ther. 2001 Aug;17(4):305-17. doi: 10.1089/108076801753162726. J Ocul Pharmacol Ther. 2001. PMID: 11572462
Levobetaxolol (Betaxon): in vitro pharmacology, intraocular pressure lowering activity and autoradiographic localization of beta-adrenoceptors in human eyes.
Sharif NA, Crider JY, Xu SX, McLaughlin M, Davis TL. Sharif NA, et al. Among authors: mclaughlin m. Proc West Pharmacol Soc. 2001;44:65-8. Proc West Pharmacol Soc. 2001. PMID: 11793997 No abstract available.
Effects of Rho Kinase Inhibitors on Intraocular Pressure and Aqueous Humor Dynamics in Nonhuman Primates and Rabbits.
Toris CB, McLaughlin MA, Dworak DP, Fan S, Havens S, Zhan GL, Horan N, Prasanna G. Toris CB, et al. J Ocul Pharmacol Ther. 2016 Jul-Aug;32(6):355-64. doi: 10.1089/jop.2015.0116. Epub 2016 Jun 6. J Ocul Pharmacol Ther. 2016. PMID: 27266531
Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.
Sharif NA, McLaughlin MA, Kelly CR, Katoli P, Drace C, Husain S, Crosson C, Toris C, Zhan GL, Camras C. Sharif NA, et al. Exp Eye Res. 2009 Mar;88(3):386-97. doi: 10.1016/j.exer.2008.10.003. Epub 2008 Nov 1. Exp Eye Res. 2009. PMID: 18992242
Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
Sharif NA, McLaughlin MA, Kelly CR, Xu S, Crider JY, Williams GW, Parker JL. Sharif NA, et al. J Ocul Pharmacol Ther. 2006 Oct;22(5):291-309. doi: 10.1089/jop.2006.22.291. J Ocul Pharmacol Ther. 2006. PMID: 17076623
Effects of a prostaglandin DP receptor agonist, AL-6598, on aqueous humor dynamics in a nonhuman primate model of glaucoma.
Toris CB, Zhan GL, Feilmeier MR, Camras CB, McLaughlin MA. Toris CB, et al. J Ocul Pharmacol Ther. 2006 Apr;22(2):86-92. doi: 10.1089/jop.2006.22.86. J Ocul Pharmacol Ther. 2006. PMID: 16722794
Effects of brinzolamide on aqueous humor dynamics in monkeys and rabbits.
Toris CB, Zhan GL, McLaughlin MA. Toris CB, et al. J Ocul Pharmacol Ther. 2003 Oct;19(5):397-404. doi: 10.1089/108076803322472962. J Ocul Pharmacol Ther. 2003. PMID: 14583132
In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma.
Chen HH, Namil A, Severns B, Ward J, Kelly C, Drace C, McLaughlin MA, Yacoub S, Li B, Patil R, Sharif N, Hellberg MR, Rusinko A, Pang IH, Combrink KD. Chen HH, et al. Bioorg Med Chem Lett. 2014 Apr 15;24(8):1875-9. doi: 10.1016/j.bmcl.2014.03.017. Epub 2014 Mar 19. Bioorg Med Chem Lett. 2014. PMID: 24684843
Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: synthesis and biological activity.
Feng Z, Hellberg MR, Sharif NA, McLaughlin MA, Williams GW, Scott D, Wallace T. Feng Z, et al. Bioorg Med Chem. 2009 Jan 15;17(2):576-84. doi: 10.1016/j.bmc.2008.11.070. Epub 2008 Dec 6. Bioorg Med Chem. 2009. PMID: 19101156
Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity.
Feng Z, Mohapatra S, Klimko PG, Hellberg MR, May JA, Kelly C, Williams G, McLaughlin MA, Sharif NA. Feng Z, et al. Bioorg Med Chem Lett. 2007 Jun 1;17(11):2998-3002. doi: 10.1016/j.bmcl.2007.03.073. Epub 2007 Mar 25. Bioorg Med Chem Lett. 2007. PMID: 17419053
1,264 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback